|
|
|
Volumn 26, Issue 5 SUPPL. 14, 1999, Pages 26-33
|
|
Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: Regulators of growth fraction and programmed cell death
a
a
NONE
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
MONOCLONAL ANTIBODY;
MONOCLONAL ANTIBODY CD 20;
PREDNISONE;
PROTEIN BAX;
PROTEIN BCL 2;
PROTEIN P21;
PROTEIN P27;
PROTEIN P53;
RITUXIMAB;
UNCLASSIFIED DRUG;
VINCRISTINE;
APOPTOSIS;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CELL CYCLE;
CELL PROLIFERATION;
CLINICAL FEATURE;
CLINICAL TRIAL;
HUMAN;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
PROGNOSIS;
ANTIBODIES, MONOCLONAL;
ANTIGENS, CD20;
ANTINEOPLASTIC AGENTS;
APOPTOSIS;
BIOLOGICAL RESPONSE MODIFIERS;
CELL CYCLE;
CELL DIVISION;
GENES, P53;
HUMANS;
LYMPHOMA, NON-HODGKIN;
PROGNOSIS;
|
|
EID: 0032692918
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (58)
|
